Recursion Pharmaceuticals, Inc.

RXRX

$3.74

Name : Recursion Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,005,653,760.00

EPSttm : -1

Recursion Pharmaceuticals, Inc.

$3.74

3.86%

$0.15

RXRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

37.13

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

0.02

EPS Last/This Y

0.51

EPS This/Next Y

0.03

Price

3.74

Target Price

7.22

Analyst Recom

2.14

Performance Q

6.25

Upside

-461.5%

Beta

1.05

Ticker: RXRX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	RXRX	3.35	0.25	0.14	397500
2026-08-31	RXRX	3.39	0.25	0.07	388232
2026-09-02	RXRX	3.38	0.25	0.03	393981
2026-09-03	RXRX	3.42	0.25	0.14	394901
2026-09-04	RXRX	3.61	0.25	0.20	395858
2026-09-08	RXRX	3.44	0.26	0.19	391381
2026-09-09	RXRX	3.22	0.26	0.15	394590
2026-09-10	RXRX	3.16	0.26	0.22	399377
2026-09-11	RXRX	3.19	0.26	0.13	401477
2026-09-14	RXRX	3.4	0.26	0.12	393468
2026-09-15	RXRX	3.24	0.26	0.11	397045
2026-09-16	RXRX	3.18	0.26	0.20	399799
2026-09-17	RXRX	3.54	0.26	0.11	400243
2026-09-18	RXRX	3.83	0.25	0.18	413335
2026-09-21	RXRX	3.97	0.18	0.05	317284
2026-09-22	RXRX	4.05	0.17	0.05	338142
2026-09-23	RXRX	3.71	0.16	0.08	348936
2026-09-24	RXRX	3.87	0.16	0.03	352988
2026-09-25	RXRX	3.74	0.16	0.17	355131
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	RXRX	3.33	36.4	-	-0.92
2026-08-31	RXRX	3.39	36.4	-	-0.92
2026-09-01	RXRX	3.33	36.4	-	-0.92
2026-09-02	RXRX	3.38	36.4	-	-0.92
2026-09-03	RXRX	3.42	36.4	-	-0.92
2026-09-04	RXRX	3.64	36.4	-	-0.92
2026-09-08	RXRX	3.44	36.4	-	-0.92
2026-09-10	RXRX	3.16	36.4	-	-0.92
2026-09-11	RXRX	3.19	36.4	-	-0.92
2026-09-14	RXRX	3.40	36.4	-	-0.92
2026-09-15	RXRX	3.24	36.4	-	-0.92
2026-09-16	RXRX	3.24	36.4	-	-0.92
2026-09-17	RXRX	3.55	36.4	-	-0.92
2026-09-18	RXRX	3.83	36.4	-	-0.92
2026-09-21	RXRX	3.97	36.4	-	-0.92
2026-09-22	RXRX	4.05	36.4	-	-0.92
2026-09-23	RXRX	3.71	36.4	-	-0.92
2026-09-24	RXRX	3.88	36.0	-	-0.93
2026-09-25	RXRX	3.74	36.0	-	-0.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	RXRX	-1.13	3.43	37.05
2026-08-31	RXRX	-1.13	3.45	37.05
2026-09-01	RXRX	-1.13	3.45	37.05
2026-09-02	RXRX	-1.13	3.45	37.05
2026-09-03	RXRX	-1.18	3.45	37.05
2026-09-04	RXRX	-1.18	3.45	37.05
2026-09-08	RXRX	-0.88	3.47	37.04
2026-09-09	RXRX	-0.88	3.47	37.04
2026-09-10	RXRX	-0.88	3.47	37.04
2026-09-11	RXRX	-0.92	3.47	37.30
2026-09-14	RXRX	-0.87	3.47	37.21
2026-09-15	RXRX	-0.89	3.47	37.21
2026-09-16	RXRX	-0.89	3.47	37.21
2026-09-17	RXRX	-0.89	3.47	37.21
2026-09-18	RXRX	-0.89	3.47	37.21
2026-09-21	RXRX	-0.88	3.49	37.21
2026-09-23	RXRX	-0.88	3.49	37.21
2026-09-24	RXRX	-0.88	3.49	37.21
2026-09-25	RXRX	-0.88	3.49	37.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.23

Insider Transactions

-0.88

Institutional Transactions

3.49

Beta

1.05

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.6

Max Drawdown 5-Year %

-88.5

Target Price

7.22

P/E

Forward P/E

PEG

P/S

36.57

P/B

2.18

P/Free Cash Flow

EPS

-1.04

Average EPS Est. Cur. Y

-0.93

EPS Next Y. (Est.)

-0.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-945.92

Relative Volume

0.51

Return on Equity vs Sector %

-83

Return on Equity vs Industry %

-63.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ RXRX Healthcare

$3.74

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

8/15

Valuation

12/20

TP/AR

3/10

Options

8/10

RSI

55.4

Range 1M

64.6%

Sup Dist

1.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

13/30

Estimates

2/20

Inst/Vol

5/15

Options

8/10

EPS Yr

37.2%

EPS NY

0.5%

52W%

23%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +93% upside

Quality

2/30

Valuation

16/30

Growth

11/25

Stability

8/10

LT Trend

2/5

Upside

+93%

Quality

RXRX — P/E HistoricalBiotechnology

Recursion Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 600

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

RXRX

Latest News

—

Caricamento notizie per RXRX…

stock quote shares RXRX – Recursion Pharmaceuticals, Inc. Stock Price stock today

news today RXRX – Recursion Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RXRX – Recursion Pharmaceuticals, Inc. yahoo finance google finance

stock history RXRX – Recursion Pharmaceuticals, Inc. invest stock market

stock prices RXRX premarket after hours

ticker RXRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RXRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y